Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 4.980
+0.060 (1.22%)
Jul 29, 2026, 3:04 PM CST
SHE:300158 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,942 | 5,765 | 4,343 | 6,936 | 7,655 | 8,415 | |
Market Cap Growth | -31.13% | 32.75% | -37.38% | -9.40% | -9.04% | 48.91% |
Enterprise Value | 4,369 | 4,977 | 2,529 | 4,612 | 5,035 | 8,202 |
Last Close Price | 4.98 | 5.81 | 4.32 | 6.75 | 7.45 | 6.24 |
PE Ratio | - | - | - | - | - | 3.22 |
Forward PE | - | 12.38 | 12.38 | 12.38 | 12.38 | 12.38 |
PS Ratio | 1.85 | 2.07 | 1.46 | 1.91 | 2.05 | 1.65 |
PB Ratio | 1.49 | 1.74 | 1.19 | 1.35 | 1.47 | 1.05 |
P/TBV Ratio | 1.64 | 1.92 | 1.28 | 1.42 | 1.55 | 1.08 |
P/FCF Ratio | - | - | - | - | - | 63.37 |
P/OCF Ratio | - | - | - | - | 94.13 | 29.58 |
EV/Sales Ratio | 1.63 | 1.79 | 0.85 | 1.27 | 1.35 | 1.61 |
EV/EBITDA Ratio | - | - | - | 208.18 | 438.26 | 29.94 |
EV/EBIT Ratio | - | - | - | - | - | 55.11 |
EV/FCF Ratio | - | - | - | - | - | 61.77 |
Debt / Equity Ratio | 0.08 | 0.06 | 0.01 | 0.00 | 0.00 | 0.04 |
Debt / EBITDA Ratio | - | - | - | 0.14 | 1.90 | 1.14 |
Debt / FCF Ratio | - | - | - | - | - | 2.36 |
Net Debt / Equity Ratio | -0.16 | -0.25 | -0.42 | -0.44 | -0.52 | -0.67 |
Net Debt / EBITDA Ratio | 2.74 | 4.32 | 2.95 | -101.37 | -236.55 | -19.63 |
Net Debt / FCF Ratio | 0.88 | 1.28 | 3.43 | 6.15 | 42.14 | -40.51 |
Asset Turnover | 0.59 | 0.58 | 0.53 | 0.57 | 0.45 | 0.58 |
Inventory Turnover | 2.01 | 1.95 | 1.84 | 1.61 | 1.88 | 2.34 |
Quick Ratio | 1.65 | 1.53 | 1.88 | 3.43 | 2.98 | 3.97 |
Current Ratio | 2.32 | 2.10 | 2.56 | 4.86 | 4.04 | 4.68 |
Return on Equity (ROE) | -8.81% | -8.70% | -30.28% | -0.92% | -0.86% | 38.13% |
Return on Assets (ROA) | -4.24% | -3.95% | -7.10% | -0.98% | -0.86% | 1.05% |
Return on Invested Capital (ROIC) | -11.72% | -13.15% | -25.26% | -3.68% | -4.42% | 3.19% |
Return on Capital Employed (ROCE) | -9.10% | -9.00% | -17.00% | -1.90% | -2.10% | 1.80% |
Earnings Yield | -6.14% | -5.22% | -30.59% | -0.63% | -0.67% | 31.10% |
FCF Yield | -12.28% | -11.09% | -10.32% | -5.27% | -0.84% | 1.58% |
Dividend Yield | - | - | - | - | - | 44.90% |
Payout Ratio | - | - | - | - | - | 7.45% |
Buyback Yield / Dilution | 0.73% | 1.91% | 0.38% | 0.02% | -0.04% | 0.01% |
Total Shareholder Return | 0.73% | 1.91% | 0.38% | 0.02% | -0.04% | 44.90% |